skip to main content

    Updated Visitor Guidelines

 

MENU

 

News Archive

Next-Generation Sequencing for Benefits Patients with Advanced Cancer
Date: 03/12/2021
When standard cancer treatments don’t work, or if doctors can’t determine where a patient’s cancer originated, genomic sequencing can help pinpoint mutations in a tumor that might be matched with medicines targeting those specific alterations.
Expanded lung cancer screening eligibility would save lives
Date: 03/10/2021
The modeling study looks at the benefits and harms associated with various low-dose computed tomography screening strategies—identifying those that result in the most benefits for a given level of screening.
Combating Structural Racism in Medicine
Date: 03/10/2021
Randy Vince Jr., M.D. dedicates his career to debunking false notions about racial biology.
Rogel Cancer Center Infusion Pharmacy Renovation to Begin March 15
Date: 03/04/2021
Beginning March 15, 2021 the mechanical system controlling the infusion pharmacy within the cancer center building will undergo corrective renovation. The planned reopening of the Rogel infusion pharmacy is May 3.
University of Michigan Research Teams Compete in the Annual STAT Madness Tournament
Date: 03/03/2021
This year, the University of Michigan is fielding five research teams -- two focused on cancer research.
New Model Predicts Drug's Success Across and Within Cancer Types
Date: 03/01/2021
New technologies and large, “-omics” datasets are now allowing researchers to examine shared features not just within a single type of cancer — such as breast cancer — but to look for patterns across many types of cancer.
Hawley to oversee Rogel Cancer Center education, training programs
Date: 02/25/2021
Sarah Hawley, Ph.D., M.P.H., will serve as associate director for training, education and career development for the Rogel Cancer Center.
A New Urine Test is Very Accurate at Detecting Aggressive Prostate Cancer
Date: 02/18/2021
The MyProstateScore test measures levels of cancer-specific genes in a patient’s urine. It's based on U-M research that half of all prostate tumors harbor a certain genetic anomaly in which the genes TMPRSS2 and ERG relocate on a chromosome and fuse together -- creating an on-switch for prostate cancer development.
U-M Rogel Cancer Center Urges Priority Access to the COVID-19 Vaccines for Cancer Patients and Survivors
Date: 02/17/2021
130 organizations and cancer centers underscore the importance of prioritizing patients with active cancer and survivors of cancer for lifesaving COVID-19 vaccines.
Combination treatment for common glioma type shows promise in mice
Date: 02/16/2021
These encouraging results, published in the Journal of Clinical Investigation, could be the first step toward developing a treatment for this type of brain cancer.

Pages